Thrombospondin1 antagonist peptide treatment attenuates obesity-associated chronic inflammation and metabolic disorders in a diet-induced obese mouse model

Qi Zhou(Purdue University West Lafayette), Shuxia Wang(Beijing Institute of Petrochemical Technology)
Scientific Reports
November 18, 2023
Cited by 7


Related Papers